Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...
Teleflex Incorporated announced the presentation of multiple clinical studies at the 2025 American Urological Association Annual Meeting in Las Vegas, highlighting advancements in treatments for ...
Boston Scientific is an advertiser of Sonoran Living. Rezūm™ Water Vapor Therapy — a minimally invasive in-office procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just ...
Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback